Login / Signup

The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.

Alexandre E MalekPaulette Pinargote CornejoNour DaoudMohammad Alam
Published in: Immunotherapy (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • dna damage
  • cell cycle
  • binding protein
  • respiratory syndrome coronavirus
  • mesenchymal stem cells
  • cell proliferation